Pharmaceuticals

Mon, 03/09/2009 - 14:50

MoH suspends use, sales of Yixin Pharma injection

Shanghai. March 9. INTERFAX-CHINA - The Ministry of Health (MoH) has suspended the use and sales of pantoprazole sodium injections manufactured by Jilin Yixin Pharmaceutical Co. Ltd., it announced on March 7.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW